Jan 11, 2021 / 12:30PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to introduce Giovanni Caforio, Chairman and CEO of Bristol-Myers to once again kick off the 39th annual and hopefully only virtual JPMorgan conference.
Before I turn it over to Giovanni, I just want to remind everybody, this is a 40-minute session. And if anybody has a question for the Q&A portion of today's meeting, (Operator Instructions).
With that, I'll turn the floor over to Giovanni.
Giovanni Caforio - Bristol-Myers Squibb Company - Chairman of the Board & CEO
Thank you, Chris, and good morning. Good morning, everyone. It's great to be here at JPMorgan again this year, although virtually.
And on Slide 2, you can see our forward-looking statements.
Let me start on Slide 3 by briefly reminding you about our strategy, which is to combine the innovation and agility of biotech with the strength and resources of a pharmaceutical company. As you know, this
Bristol-Myers Squibb Co at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers